Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Biomedical Research (OBR) is a Michigan-based biotechnology company that develops and manufactures specialized research reagents and assay kits for the global scientific community. Established in 1984, the company is a leader in providing tools for the study of oxidative stress, inflammation, and metabolic diseases. Their product line features a comprehensive range of assays for eicosanoids, cytochrome P450 enzymes, and antioxidant capacity, as well as custom assay development services. OBR's products are widely utilized in academic research, pharmaceutical drug discovery, and environmental testing. The company is recognized for its technical expertise in biochemical analysis and its contribution to advancing the understanding of chronic disease mechanisms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Biomedical Research.